TR201819658T4 - Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu - Google Patents

Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu Download PDF

Info

Publication number
TR201819658T4
TR201819658T4 TR2018/19658T TR201819658T TR201819658T4 TR 201819658 T4 TR201819658 T4 TR 201819658T4 TR 2018/19658 T TR2018/19658 T TR 2018/19658T TR 201819658 T TR201819658 T TR 201819658T TR 201819658 T4 TR201819658 T4 TR 201819658T4
Authority
TR
Turkey
Prior art keywords
adapalene
bpo
combination
lesions
acne
Prior art date
Application number
TR2018/19658T
Other languages
English (en)
Turkish (tr)
Inventor
Abou-Chacra Vernet Marie-Line
Gross Denis
Loesche Christian
Poncet Michel
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37763873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201819658(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of TR201819658T4 publication Critical patent/TR201819658T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TR2018/19658T 2006-07-13 2007-07-12 Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu TR201819658T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0652968A FR2903603B1 (fr) 2006-07-13 2006-07-13 Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US83349106P 2006-07-27 2006-07-27

Publications (1)

Publication Number Publication Date
TR201819658T4 true TR201819658T4 (tr) 2019-01-21

Family

ID=37763873

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19658T TR201819658T4 (tr) 2006-07-13 2007-07-12 Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu

Country Status (23)

Country Link
US (6) US8129362B2 (pt)
EP (2) EP2046318B1 (pt)
JP (3) JP2009542779A (pt)
KR (3) KR20160120352A (pt)
CN (1) CN101541320B (pt)
AR (1) AR061989A1 (pt)
AU (1) AU2007274288B2 (pt)
BR (1) BRPI0713182A8 (pt)
CA (1) CA2656456A1 (pt)
CO (1) CO6150136A2 (pt)
CY (1) CY1121398T1 (pt)
DK (2) DK2046318T3 (pt)
ES (2) ES2423951T3 (pt)
FR (1) FR2903603B1 (pt)
HU (1) HUE043502T2 (pt)
LT (1) LT2450035T (pt)
MX (1) MX2009000319A (pt)
PL (2) PL2046318T3 (pt)
PT (2) PT2450035T (pt)
RU (3) RU2009104949A (pt)
SI (2) SI2450035T1 (pt)
TR (1) TR201819658T4 (pt)
WO (1) WO2008006888A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
JP2011510907A (ja) * 2007-01-30 2011-04-07 ガルデルマ・リサーチ・アンド・デヴェロップメント 尋常性ざ瘡の長期間の処置のためのアダパレンおよび過酸化ベンゾイルの使用
CN101969923A (zh) * 2007-11-30 2011-02-09 盖尔德马研究及发展公司 含有至少一种萘甲酸衍生物、过氧化苯甲酰和至少一种成膜剂的组合物、它们的制备方法及其用途
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
JP2013518920A (ja) * 2010-02-09 2013-05-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 非白人系人種における炎症後色素沈着の減少と共にざ瘡の処置を目的とする、アダパレンと過酸化ベンゾイルとの組合せを含む皮膚科学的組成物
CA2796412A1 (en) * 2010-04-29 2011-11-03 Galderma Research & Development Method for treating scars with adapalene 0.3%
FR2969491B1 (fr) * 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US8563535B2 (en) * 2011-03-29 2013-10-22 Kamal Mehta Combination composition comprising benzoyl peroxide and adapalene
CA2870690A1 (en) * 2012-05-25 2013-11-28 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
DK2922528T3 (en) 2012-11-20 2017-09-18 Allergan Inc TOPICAL DAPSON AND DAPSON / ADAPALEN COMPOSITIONS AND PROCEDURES FOR USE THEREOF
BR112016022743A2 (pt) * 2014-04-01 2017-08-15 Galderma Res & Dev Método para tratar e/ou evitar pelo menos uma cicatriz de acne, uso de uma combinação fixa de adapaleno e peróxido de benzoíla e composição
SMT202000705T1 (it) 2014-07-25 2021-01-05 Galderma Res & Dev Combinazione di adapalene e benzoilperossido per il trattamento di acne grave
WO2017029665A1 (en) * 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
JP6679299B2 (ja) * 2015-12-21 2020-04-15 第一三共ヘルスケア株式会社 ニキビ治療用外用医薬組成物
KR101986177B1 (ko) * 2016-10-31 2019-06-05 (주)동구바이오제약 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물
WO2018080284A1 (ko) * 2016-10-31 2018-05-03 (주)동구바이오제약 여드름 치료용 약물의 생체이용률을 증진시키는 약학적 조성물
MX395001B (es) * 2017-03-08 2025-03-24 Centro Int De Cosmiatria S A P I De C V Composición y método para el tratamiento tópico del acné severo.
CN110913849A (zh) * 2017-03-30 2020-03-24 科学派有限责任公司 治疗和预防感染的方法
JP2022542616A (ja) 2019-08-01 2022-10-05 ボシュ ヘルス アイルランド リミテッド 局所組成物
EP4493179A4 (en) * 2022-03-14 2026-04-22 Blue Hill Tech Llc LONG-SHELF BENZOYL PEROXIDE FORMULATIONS AND THEIR PRODUCTION PROCESSES

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
FR2727609B1 (fr) 1994-12-06 1997-01-10 Oreal Ensemble de distribution pour l'application d'un produit de consistance liquide a pateuse
FR2775566B1 (fr) 1998-03-03 2000-05-12 Oreal Cupule porte raisin et ensemble de conditionnement pour un produit de maquillage la comportant
US6559189B2 (en) * 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
FR2806273B1 (fr) 2000-03-16 2002-10-04 Oreal Dispositif de conditionnement et d'application d'un produit cosmetique ou de soin
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
FR2837101B1 (fr) 2002-03-12 2004-07-02 Galderma Res & Dev Utilisation de l'acide 6-[1-adamantyl)-4-methoxyphenyl]-2- naphthoique pour le traitement de desordres dermatologiques
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
WO2005009458A1 (en) 2003-07-23 2005-02-03 Xoma Technology Ltd. Use of xmp-629 for the treatment of acne
US20050239723A1 (en) 2004-04-27 2005-10-27 Amin Avinash N Compositions and methods useful for treatment of acne
US20060128808A1 (en) 2004-10-20 2006-06-15 Galderma Research & Development, S.N.C. Method of using adapalene in acne maintenance therapy
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
FR2901139B1 (fr) 2006-05-17 2009-03-20 Galderma Res & Dev S N C Snc Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations

Also Published As

Publication number Publication date
US8071644B2 (en) 2011-12-06
FR2903603B1 (fr) 2009-03-20
CY1121398T1 (el) 2020-05-29
KR20090028764A (ko) 2009-03-19
US8129362B2 (en) 2012-03-06
CO6150136A2 (es) 2010-04-20
EP2046318A1 (en) 2009-04-15
RU2012144414A (ru) 2014-04-27
WO2008006888A1 (en) 2008-01-17
AR061989A1 (es) 2008-08-10
US20140296340A1 (en) 2014-10-02
HUE043502T2 (hu) 2019-08-28
US20080033047A1 (en) 2008-02-07
EP2046318B1 (en) 2013-06-05
EP2450035A1 (en) 2012-05-09
US20120059063A1 (en) 2012-03-08
DK2046318T3 (da) 2013-08-05
DK2450035T3 (en) 2019-02-25
MX2009000319A (es) 2009-03-12
US20090253788A1 (en) 2009-10-08
SI2450035T1 (sl) 2019-03-29
ES2703505T3 (es) 2019-03-11
KR20150003917A (ko) 2015-01-09
JP2009542779A (ja) 2009-12-03
EP2450035B1 (en) 2018-11-21
JP2016029094A (ja) 2016-03-03
CN101541320B (zh) 2014-04-09
CN101541320A (zh) 2009-09-23
FR2903603A1 (fr) 2008-01-18
ES2423951T3 (es) 2013-09-25
US20170202803A1 (en) 2017-07-20
PL2046318T3 (pl) 2013-12-31
PT2450035T (pt) 2019-02-26
AU2007274288A1 (en) 2008-01-17
LT2450035T (lt) 2019-01-25
US8785420B2 (en) 2014-07-22
BRPI0713182A2 (pt) 2012-04-17
RU2012136952A (ru) 2014-03-10
BRPI0713182A8 (pt) 2018-01-02
AU2007274288B2 (en) 2013-05-02
PL2450035T3 (pl) 2019-04-30
SI2046318T1 (sl) 2013-11-29
JP2014040481A (ja) 2014-03-06
CA2656456A1 (en) 2008-01-17
KR20160120352A (ko) 2016-10-17
US20120115947A1 (en) 2012-05-10
RU2009104949A (ru) 2010-08-20
PT2046318E (pt) 2013-09-04

Similar Documents

Publication Publication Date Title
TR201819658T4 (tr) Akne Lezyonlarını Tedavi Etmek İçin Adapalen Ve Benzoil Peroksit Kombinasyonu
US20210077509A1 (en) Compositions for the improved treatment of acne and related disorders
US8313782B2 (en) Acne vulgaris treatment regimen
CN1642538B (zh) 阿达帕林治疗皮肤病的用途
CN103957866B (zh) 用于痤疮患者的局部用洗液组合物
CA2332808C (en) Compositions of ascorbic acid derivatives for treatment of skin diseases
CA2995794A1 (en) Tetracycline management of egfr inhibitor associated dermatoses
CN101969923A (zh) 含有至少一种萘甲酸衍生物、过氧化苯甲酰和至少一种成膜剂的组合物、它们的制备方法及其用途
US20190307778A1 (en) Tetracycline management of egfr inhibitor associated dermatoses
KR20070067198A (ko) 여드름 유지 요법에서 아다팔렌을 사용하는 방법
US20140199413A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
US9572777B2 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine
US8673356B2 (en) Stable fixed dose topical formulation
JP2011528377A (ja) 座瘡治療のための方法及び物質
US10123970B2 (en) Topical retinoid solutions
US20250099492A1 (en) Compositions for the improved treatment of acne and related disorders
AU2020204232B2 (en) Compositions that assist skin healing and/or maintain skin health
JP2002332237A (ja) 皮膚外用剤
EP3220903A1 (fr) Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne
JPWO2020116570A1 (ja) 皮膚外用剤
US20170095434A1 (en) Combination of adapalene and benzoyl peroxide for the treatment of severe acne
Kircik Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in the treatment of severe acne Guy Webster, Jefferson Medical College, Hoclessin, DE, United States; Michael Gold, MD, Tennessee Clinical, Nashville, TN, United States; Phoebe Rich, MD
WO2018109541A1 (en) Aluminium fluoride and sulfur for the treatment of acne vulgaris
FR3028763A1 (fr) Compositions comprenant un compose de la famille des avermectines et un compose antagoniste d'au moins un des recepteurs rar pour le traitement de l'acne
JPWO1999059580A1 (ja) 皮膚疾患予防治療剤